BEAM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Beam Therapeutics Inc

Watchlist Manager

Watchlist

Price: 29.66 USD 0.68%

Market Cap: $3.1B

	Beam Therapeutics Inc NASDAQ:BEAM	US
	Oxford Square Capital Corp F:22T	US
	MatsukiyoCocokara & Co OTC:MSMKF	JP
C	Cummins Inc XMUN:CUM	US
8	8x8 Inc NASDAQ:EGHT	US

Profitability Summary

Beam Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-242%

Negative 3Y Average Operating Margin

-362%

Operating Margin is Increasing

-476% > -242%

Negative Net Margin

-55%

Negative 3Y Average Net Margin

-275%

Net Margin is Increasing

-408% > -55%

Negative Free Cash Flow Margin

-239%

Negative 3Y Average Free Cash Flow Margin

-312%

Free Cash Flow Margin is Increasing

-475% > -239%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-136%

Declining ROIC

-147% > -168%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.